Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Anesthesiology

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000542-199211000-00010PMID 1443743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia.

  1991cited by this paper
• Intraoperative blood volume expansion induces primary function after renal transplantation: a study of 96 paired cadaver kidneys.

  1991cited by this paper
• Pharmacokinetics and Pharmacodynamics of Doxacurium in Normal Patients and in Those With Hepatic or Renal Failure

  1991cited by this paper
• Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.

  1990cited by this paper
• The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat.

  1990cited by this paper
• Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations.

  1989cited by this paper
• The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide.

  1989cited by this paper
• Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection.

  1988cited by this paper
• The Pharmacodynamics and Pharmacokinetics of Vecuronium in Patients Anesthetized with Isoflurane with Normal Renal Function or with Renal Failure

  1988cited by this paper
• Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.

  1987cited by this paper
• The Pharmacokinetics and Pharmacodynamics of Atracurium in Patients with and without Renal Failure

  1984cited by this paper
• MAXIMAL HYDRATION DURING ANESTHESIA INCREASES PULMONARY ARTERIAL PRESSURES AND IMPROVES EARLY FUNCTION OF HUMAN RENAL TRANSPLANTS

  1982cited by this paper
• The pharmacokinetics of d-tubocurarine in man with and without renal failure.

  1977cited by this paper
• The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide

  1977cited by this paper

• Mechanism-Based Modeling of Neuromuscular Monitoring Measures During General Anesthesia

  2025cites this paper
• Reversal of neuromuscular blockade with sugammadex based on the residual amount of rocuronium in the body using pharmacokinetic simulation

  2025cites this paper
• Propriétés allergiques et activatrices de MRGPRX2 des médicaments : vers un algorithme mécanistique résolutif

  2024cites this paper
• Pharmacokinetic simulation can detect erroneous TOF counts

  2024cites this paper
• Neuromuscular end-point predictive capability of published rocuronium pharmacokinetic/pharmacodynamic models: An observational trial.

  2023cites this paper
• Allergenic and MRGPRX2-activating properties of drugs: resolving the two.

  2022cites this paper
• Comparison of two pharmacokinetic-pharmacodynamic models of rocuronium bromide during profound neuromuscular block: analysis of estimated and measured post-tetanic count effect.

  2022cites this paper
• MRGPRX2 and Adverse Drug Reactions

  2021cites this paper
• A Case of Respiratory Arrest Caused by Recurarization and Treated with Sugammadex through Antagonism of Neuromuscular Block

  2021cites this paper
• Anesthetic drugs: a comprehensive overview for anesthesiologists

  2021cites this paper
• The evolution of pharmacokinetics.

  2020cites this paper
• The Perioperative Management of the Patient with Chronic Kidney Disease

  2020cites this paper
• Rocuronium Has a Suppressive Effect on Platelet Function via the P2Y12 Receptor Pathway In Vitro That Is Not Reversed by Sugammadex

  2020cites this paper
• Anästhesie bei Patienten mit Niereninsuffizienz und Nierenversagen

  2019cites this paper
• Neuromuscular Blockers and Reversal Drugs

  2019cites this paper
• Rocuronium pharmacodynamic models for published five pharmacokinetic models: age and sex are covariates in pharmacodynamic models

  2018cites this paper
• Method for Prediction of Efficacy of Sugammadex Administered to Recover from Rocuronium-Induced Neuromuscular Blockade in Gynecological Laparoscopic Surgery Cases.

  2018cites this paper
• Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers

  2018cites this paper
• The Effects of High Dose Sugammadex on Rat Kidney Tissue Following Unilateral Ureteral Obstruction Unilateral

  2018cites this paper
• Rocuronium bromide: clinical application of single-dose pharmacokinetic models to continuous infusion

  2018cites this paper
• Dilemma In Rapid Sequence Intubation : Succinylcholine Vs .

  2018cites this paper
• Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant

  2018cites this paper
• Increased Renal Clearance of Rocuronium Compensates for Chronic Loss of Bile Excretion, via upregulation of Oatp2

  2017cites this paper
• Neuromuscular Blocking Drugs: Physiology, Pharmacology and Clinical Aspects

  2017cites this paper
• Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents

  2017cites this paper
• Farmacocinética y farmacodinamia

  2017cites this paper
• Rocuronium bromide

  2017cites this paper
• Effects of Sugammadex and Neostigmine on Renal Biomarkers

  2016cites this paper
• The predictive ability of six pharmacokinetic models of rocuronium developed using a single bolus: evaluation with bolus and continuous infusion regimen

  2016cites this paper
• Anesthetic pharmacology for kidney transplantation.

  2015cites this paper
• The Perioperative Management of the Chronic Kidney Disease Patient

  2015cites this paper
• Drug Information Rounds

  2015cites this paper
• A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF ROCURONIUM AND VECURONIUM FOR RAPID SEQUENCE INTUBATION IN ADULTS

  2015cites this paper
• Neuromuscular blocking agents

  2015cites this paper
• Dexamethasone Produces Dose-Dependent Inhibition of Sugammadex Reversal in In Vitro Innervated Primary Human Muscle Cells

  2014cites this paper
• Dräger SmartPilot ViewTM─バランス麻酔のビジュアル化とその教育的価値─

  2014cites this paper
• Suppression of the cough reflex by α2-adrenergic receptor agonists in the rabbit

  2013cites this paper
• The Use of Neuromuscular Blocking Agents in the ICU: Where Are We Now?

  2013cites this paper
• Chapter 19 – Neuromuscular Blockers and Reversal Drugs

  2013cites this paper
• Anästhesie bei Niereninsuffizienz und Nierenversagen

  2012cites this paper
• Influence of real-time Bayesian forecasting of pharmacokinetic parameters on the precision of a rocuronium target-controlled infusion

  2012cites this paper
• EPSAC Predictive Control Applied to Muscle Relaxant Administration

  2012influential citation
• Effect of ulinastatin on the rocuronium-induced neuromuscular blockade

  2012cites this paper
• Chapter 122 – Neuromuscular Blocking Agents

  2011cites this paper
• [Characteristics of neuromuscular block after administration of rocuronium bromide in patients with end-stage renal failure].

  2011cites this paper
• Reversal of Rocuronium-Induced Neuromuscular Block with Sugammadex and Resulting Histopathological Effects in Rat Kidneys

  2011cites this paper
• Pharmacology of Muscle Relaxants and Their Antagonists

  2010cites this paper
• Sugammadex in anesthesia practice

  2010cites this paper
• Farmacocinética y farmacodinamia del bromuro de rocuronio: Influencia de la terapia crónica con fenitoína.

  2010cites this paper
• Anesthesia and the Renal and Genitourinary Systems

  2010cites this paper
• Newer Agents for Rapid Sequence Intubation: Etomidate and Rocuronium

  2009cites this paper
• Time course of neuromuscular effects of rocuronium during desflurane anesthesia in patients with or without renal failure.

  2009cites this paper
• Clinical use of rocuronium in patients with end-stage renal disease.

  2009cites this paper
• Chapter 13 – Anesthesia for Patients Undergoing Renal Transplantation

  2008cites this paper
• 特殊な状態・病態におけるロクロニウムの使い方と留意点—肝臓・腎臓障害および移植術—

  2008cites this paper
• Pharmacokinetic–pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery

  2008cites this paper
• [Indications and uses of neuromuscular blocking agents in the ICU].

  2008cites this paper
• Indications et utilisation des curares en réanimation

  2008cites this paper
• Factors That Affect the Onset of Muscle Relaxant

  2007cites this paper
• Pharmacokinetic–pharmacodynamic relationship of rocuronium under stable nitrous oxide–fentanyl or nitrous oxide–sevoflurane anesthesia in children

  2006cites this paper
• Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure

  2005cites this paper
• FACULTE DE MEDECINE DE PHARMACIE ET D'ODONTO- STOMATOLOGIE

  2005cites this paper
• Pharmacodynamics of rocuronium 0.3 mg kg−1 in adult patients with and without renal failure

  2005cites this paper
• Dosis efectivas de rocuronio para intubación satisfactoria en niños menores de 2 años sometidos a cirugía

  2004cites this paper
• Kidney transplantation: recent developments and recommendations for anesthetic management.

  2004cites this paper
• Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants.

  2003cites this paper
• Target controlled infusion of rocuronium: analysis of effect data to select a pharmacokinetic model.

  2003cites this paper
• The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.

  2003cites this paper
• Dilemma In Rapid Sequence Intubation: Succinylcholine Vs. Rocuronium

  2002cites this paper
• Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia

  2002cites this paper
• Neuromuscular blocking drugs in pediatric anesthesia

  2002cites this paper
• Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function.

  2002influential citation
• Time‐course of action of rocuronium 0.3 mg·kg−1 in children with and without endstage renal failure

  2002cites this paper
• Rocuronium-Induced Neuromuscular Blockade Is Affected by Chronic Phenytoin Therapy

  2001cites this paper
• The influence of halothane, isoflurane and sevoflurane on rocuronium infusion in children

  2001cites this paper
• Multicenter Trial of Prolonged Infusions of Rocuronium Bromide in Critically Ill Patients: Effects of Multiple Organ Failure

  2001cites this paper
• Cumulation characteristics of cisatracurium and rocuronium during continuous infusion

  2000cites this paper
• Emergency department use of neuromuscular blocking agents in children.

  2000cites this paper
• SKELETAL MUSCLE RELAXANTS: PHARMACODYNAMICS AND PHARMACOKINETICS IN DIFFERENT PATIENT GROUPS

  2000cites this paper
• Urinary, biliary and faecal excretion of rocuronium in humans.

  2000cites this paper
• Neuromuscular Blocking Drugs for the New Millennium: Current Practice, Future Trends—Comparative Pharmacology of Neuromuscular Blocking Drugs

  2000cites this paper
• Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy

  2000cites this paper
• Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP)

  2000cites this paper
• New Neuromuscular Blocking Agents and Fast-Tracking Anaesthesia

  2000cites this paper
• Tempo de latencia e duracao do efeito do brometo de rocuronio no paciente submetido ao transplante renal

  2000cites this paper
• Computer-Controlled Infusion of Neuromuscular Blocking Agents

  2000cites this paper
• Intraocular pressure changes during rapid sequence induction and intubation: a comparison of rocuronium, atracurium, and succinylcholine.

  1999cites this paper
• Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy.

  1999cites this paper
• Prolonged neuromuscular blockade associated with rocuronium.

  1999cites this paper
• Succinylcholine: adverse effects and alternatives in emergency medicine.

  1999cites this paper
• A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide.

  1999cites this paper
• [The use of curare-like agents in resuscitation].

  1999cites this paper
• Clinical Pharmacokinetics of the Newer Neuromuscular Blocking Drugs

  1999cites this paper
• Anaesthesia for renal transplantation

  1999cites this paper
• Utilisation des curares en réanimation

  1999cites this paper
• Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide.

  1999cites this paper
• Pharmacokinetics of rocuronium bromide in obese female patients.

  1999cites this paper
• Assessment of total intravenous anesthesia in renal transplantation.

  1998cites this paper
• Population based pharmacokinetic analysis: why do we need it; what is it; and what has it told us about anaesthetics?

  1998cites this paper
• Pharmacologie des curares

  1998cites this paper